The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder
Raghda Elsherif,
No information about this author
Amel M.M. Abdel-Hafez,
No information about this author
Ola A. Hussein
No information about this author
et al.
Journal of Molecular Histology,
Journal Year:
2025,
Volume and Issue:
56(1)
Published: Jan. 6, 2025
Language: Английский
Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
In
this
review,
it
is
evaluated
the
progress
in
application
of
stem
cell
therapy
to
ameliorate
symptoms
bipolar
disorder,
major
depression,
schizophrenia,
and
autism.
These
disorders
are
highly
prevalent
clinical
medicine
responsible
for
high
levels
psychosocial
disability
among
patients.
All
them
share
common
biomedical
features,
such
as
complex
variable
genetic
substrates,
significant
susceptibility
environmental
changes,
insufficient
knowledge
their
pathogenesis.
addition,
responsiveness
patients
pharmacological
treatment
heterogeneous,
some
cases,
no
available.
Therefore,
development
cell-based
regenerative
its
possible
combination
with
emerging
therapeutic
approaches
that
promote
neural
plasticity
expected
advance
neuropsychiatry
next
few
decades.
Language: Английский
The Possible Role of Postnatal Biphasic Dysregulation of IGF-1 Tone in the Etiology of Idiopathic Autism Spectrum Disorder
András Visegrády
No information about this author
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(10), P. 4483 - 4483
Published: May 8, 2025
Autism
spectrum
disorder
(ASD)
is
a
pervasive
condition
of
neurodevelopmental
origin
with
an
increasing
burden
on
society.
Idiopathic
ASD
notorious
for
its
heterogeneous
behavioral
manifestations,
and
despite
substantial
efforts,
etiopathology
still
unclear.
An
amount
data
points
to
the
causative
role
critical
developmental
alterations
in
first
year
life,
although
contribution
fetal,
environmental,
genetic
factors
cannot
be
clearly
distinguished.
This
review
attempts
propose
narrative
starting
from
neuropathological
findings
ASD,
involving
insulin-like
growth
factor
1
(IGF-1)
as
key
modulator
demonstrates
how
most
consistent
gestational
risk
ASD–maternal
insulin
resistance
fetal
insufficiency–converge
at
perinatal
dysregulation
offspring
anabolism
period
early
development.
A
unifying
hypothesis
derived,
stating
that
co-occurrence
these
conditions
leads
postnatal
biphasic
IGF-1
tone
offspring,
leading
insulin-dependent
accelerated
development,
then
subsequent
arrest
brain
maturation
etiologic
process.
tested
explanation
various
widely
reported
observations
idiopathic
including
abnormalities,
symptoms,
familial
predisposition,
male
susceptibility.
Finally,
further
directions
research
are
outlined.
Language: Английский